Quantitative characterization of CD8+ T cell clustering and spatial heterogeneity in solid tumors

Chang Gong, Robert A. Anders, Qingfeng Zhu, Janis M. Taube, Benjamin Green, Wenting Cheng, Imke H. Bartelink, Paolo Vicini, Bing Wang, Aleksander S. Popel

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Quantitative characterization of the tumor microenvironment, including its immuno-architecture, is important for developing quantitative diagnostic and predictive biomarkers, matching patients to the most appropriate treatments for precision medicine, and for providing quantitative data for building systems biology computational models able to predict tumor dynamics in the context of immune checkpoint blockade therapies. The intra- and inter-tumoral spatial heterogeneities are potentially key to the understanding of the dose-response relationships, but they also bring challenges to properly parameterizing and validating such models. In this study, we developed a workflow to detect CD8+ T cells from whole slide imaging data, and quantify the spatial heterogeneity using multiple metrics by applying spatial point pattern analysis and morphometric analysis. The results indicate a higher intra-tumoral heterogeneity compared with the heterogeneity across patients. By comparing the baseline metrics with PD-1 blockade treatment outcome, our results indicate that the number of high-density T cell clusters of both circular and elongated shapes are higher in patients who responded to the treatment. This methodology can be applied to quantitatively characterize the tumor microenvironment, including immuno-architecture, and its heterogeneity for different cancer types.
Original languageEnglish
Article number00649
JournalFrontiers in Oncology
Volume9
Issue numberJAN
DOIs
Publication statusPublished - 2019

Cite this

Gong, C., Anders, R. A., Zhu, Q., Taube, J. M., Green, B., Cheng, W., ... Popel, A. S. (2019). Quantitative characterization of CD8+ T cell clustering and spatial heterogeneity in solid tumors. Frontiers in Oncology, 9(JAN), [00649]. https://doi.org/10.3389/fonc.2018.00649
Gong, Chang ; Anders, Robert A. ; Zhu, Qingfeng ; Taube, Janis M. ; Green, Benjamin ; Cheng, Wenting ; Bartelink, Imke H. ; Vicini, Paolo ; Wang, Bing ; Popel, Aleksander S. / Quantitative characterization of CD8+ T cell clustering and spatial heterogeneity in solid tumors. In: Frontiers in Oncology. 2019 ; Vol. 9, No. JAN.
@article{a99dc138219f4b66b949da6b2f96c6a7,
title = "Quantitative characterization of CD8+ T cell clustering and spatial heterogeneity in solid tumors",
abstract = "Quantitative characterization of the tumor microenvironment, including its immuno-architecture, is important for developing quantitative diagnostic and predictive biomarkers, matching patients to the most appropriate treatments for precision medicine, and for providing quantitative data for building systems biology computational models able to predict tumor dynamics in the context of immune checkpoint blockade therapies. The intra- and inter-tumoral spatial heterogeneities are potentially key to the understanding of the dose-response relationships, but they also bring challenges to properly parameterizing and validating such models. In this study, we developed a workflow to detect CD8+ T cells from whole slide imaging data, and quantify the spatial heterogeneity using multiple metrics by applying spatial point pattern analysis and morphometric analysis. The results indicate a higher intra-tumoral heterogeneity compared with the heterogeneity across patients. By comparing the baseline metrics with PD-1 blockade treatment outcome, our results indicate that the number of high-density T cell clusters of both circular and elongated shapes are higher in patients who responded to the treatment. This methodology can be applied to quantitatively characterize the tumor microenvironment, including immuno-architecture, and its heterogeneity for different cancer types.",
author = "Chang Gong and Anders, {Robert A.} and Qingfeng Zhu and Taube, {Janis M.} and Benjamin Green and Wenting Cheng and Bartelink, {Imke H.} and Paolo Vicini and Bing Wang and Popel, {Aleksander S.}",
year = "2019",
doi = "10.3389/fonc.2018.00649",
language = "English",
volume = "9",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S.A.",
number = "JAN",

}

Gong, C, Anders, RA, Zhu, Q, Taube, JM, Green, B, Cheng, W, Bartelink, IH, Vicini, P, Wang, B & Popel, AS 2019, 'Quantitative characterization of CD8+ T cell clustering and spatial heterogeneity in solid tumors' Frontiers in Oncology, vol. 9, no. JAN, 00649. https://doi.org/10.3389/fonc.2018.00649

Quantitative characterization of CD8+ T cell clustering and spatial heterogeneity in solid tumors. / Gong, Chang; Anders, Robert A.; Zhu, Qingfeng; Taube, Janis M.; Green, Benjamin; Cheng, Wenting; Bartelink, Imke H.; Vicini, Paolo; Wang, Bing; Popel, Aleksander S.

In: Frontiers in Oncology, Vol. 9, No. JAN, 00649, 2019.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Quantitative characterization of CD8+ T cell clustering and spatial heterogeneity in solid tumors

AU - Gong, Chang

AU - Anders, Robert A.

AU - Zhu, Qingfeng

AU - Taube, Janis M.

AU - Green, Benjamin

AU - Cheng, Wenting

AU - Bartelink, Imke H.

AU - Vicini, Paolo

AU - Wang, Bing

AU - Popel, Aleksander S.

PY - 2019

Y1 - 2019

N2 - Quantitative characterization of the tumor microenvironment, including its immuno-architecture, is important for developing quantitative diagnostic and predictive biomarkers, matching patients to the most appropriate treatments for precision medicine, and for providing quantitative data for building systems biology computational models able to predict tumor dynamics in the context of immune checkpoint blockade therapies. The intra- and inter-tumoral spatial heterogeneities are potentially key to the understanding of the dose-response relationships, but they also bring challenges to properly parameterizing and validating such models. In this study, we developed a workflow to detect CD8+ T cells from whole slide imaging data, and quantify the spatial heterogeneity using multiple metrics by applying spatial point pattern analysis and morphometric analysis. The results indicate a higher intra-tumoral heterogeneity compared with the heterogeneity across patients. By comparing the baseline metrics with PD-1 blockade treatment outcome, our results indicate that the number of high-density T cell clusters of both circular and elongated shapes are higher in patients who responded to the treatment. This methodology can be applied to quantitatively characterize the tumor microenvironment, including immuno-architecture, and its heterogeneity for different cancer types.

AB - Quantitative characterization of the tumor microenvironment, including its immuno-architecture, is important for developing quantitative diagnostic and predictive biomarkers, matching patients to the most appropriate treatments for precision medicine, and for providing quantitative data for building systems biology computational models able to predict tumor dynamics in the context of immune checkpoint blockade therapies. The intra- and inter-tumoral spatial heterogeneities are potentially key to the understanding of the dose-response relationships, but they also bring challenges to properly parameterizing and validating such models. In this study, we developed a workflow to detect CD8+ T cells from whole slide imaging data, and quantify the spatial heterogeneity using multiple metrics by applying spatial point pattern analysis and morphometric analysis. The results indicate a higher intra-tumoral heterogeneity compared with the heterogeneity across patients. By comparing the baseline metrics with PD-1 blockade treatment outcome, our results indicate that the number of high-density T cell clusters of both circular and elongated shapes are higher in patients who responded to the treatment. This methodology can be applied to quantitatively characterize the tumor microenvironment, including immuno-architecture, and its heterogeneity for different cancer types.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85063267616&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30666298

U2 - 10.3389/fonc.2018.00649

DO - 10.3389/fonc.2018.00649

M3 - Article

VL - 9

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

IS - JAN

M1 - 00649

ER -